NASDAQ:VERA

Vera Therapeutics Stock Insider Trading

etoro logo Buy VERA
*Your capital is at risk
$31.58
-1.31 (-3.98%)
At Close: Aug 10, 2026

Vera Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 3.21. In total, the insiders bought 1.9M and sold 227.93K VERA shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
3.21
Buy 1.9M shares
Sell 227.93K shares
71% Buy Activity
Negligible or No Correlation
Sell Signal Low Confidence
Jul 07, 2026

Analysis Breakdown:

  • Weakened by a contradictory positive Insider Power Score.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Jun 23, 2025
Buy
Class A Common Stock
P-Purchase
Enright Patrick G
Director
Director 69 798
Value: $1.46M
Jun 23, 2025
Buy
Class A Common Stock
P-Purchase
Enright Patrick G
Director
Director 69 798
Value: $1.46M
Jun 23, 2025
Buy
Class A Common Stock
P-Purchase
Enright Patrick G
Director
Director 139 595
Value: $2.91M
May 14, 2025
Buy
Stock Option (right to buy)
A-Award
Katabi Maha
Director
Director 14 000
Value: $296.7K
May 14, 2025
Buy
Stock Option (right to buy)
A-Award
Enright Patrick G
Director
Director 14 000
Value: $296.7K
May 14, 2025
Buy
Stock Option (right to buy)
A-Award
Oliger Christy J.
Director
Director 14 000
Value: $296.7K
May 14, 2025
Buy
Stock Option (right to buy)
A-Award
Morrissey Michael
Director
Director 14 000
Value: $296.7K
May 14, 2025
Buy
Stock Option (right to buy)
A-Award
Seidenberg Beth C
Director
Director 14 000
Value: $296.7K
May 14, 2025
Buy
Stock Option (right to buy)
A-Award
Hall Kimball
Director
Director 14 000
Value: $296.7K
May 14, 2025
Buy
Stock Option (right to buy)
A-Award
Morrison Scott W
Director
Director 14 000
Value: $296.7K
May 14, 2025
Buy
Stock Option (right to buy)
A-Award
Cheng Andrew
Director
Director 14 000
Value: $296.7K
May 14, 2025
Buy
Stock Option (right to buy)
A-Award
Cheng Andrew
Director
Director 14 000
Value: $296.7K
May 14, 2025
Buy
Stock Option (right to buy)
A-Award
Morrison Scott W
Director
Director 14 000
Value: $296.7K
May 14, 2025
Buy
Stock Option (right to buy)
A-Award
Hall Kimball
Director
Director 14 000
Value: $296.7K
May 14, 2025
Buy
Stock Option (right to buy)
A-Award
Seidenberg Beth C
Director
Director 14 000
Value: $296.7K
May 14, 2025
Buy
Stock Option (right to buy)
A-Award
Morrissey Michael
Director
Director 14 000
Value: $296.7K
May 14, 2025
Buy
Stock Option (right to buy)
A-Award
Oliger Christy J.
Director
Director 14 000
Value: $296.7K
May 14, 2025
Buy
Stock Option (right to buy)
A-Award
Enright Patrick G
Director
Director 14 000
Value: $296.7K
May 14, 2025
Buy
Stock Option (right to buy)
A-Award
Katabi Maha
Director
Director 14 000
Value: $296.7K
Feb 26, 2025
Sell
Class A Common Stock
S-Sale
Fordyce Marshall
President And CEO
CEO / President 7 975
Value: $219.7K
Feb 26, 2025
Sell
Class A Common Stock
S-Sale
Fordyce Marshall
President And CEO
CEO / President 1 100
Value: $31.2K
Feb 26, 2025
Sell
Class A Common Stock
S-Sale
Fordyce Marshall
President And CEO
CEO / President 1 100
Value: $31.2K
Feb 26, 2025
Sell
Class A Common Stock
S-Sale
Fordyce Marshall
President And CEO
CEO / President 7 975
Value: $219.7K
Feb 21, 2025
Sell
Class A Common Stock
S-Sale
Fordyce Marshall
President And CEO
CEO / President 10 613
Value: $296.0K
Feb 21, 2025
Sell
Class A Common Stock
S-Sale
Fordyce Marshall
President And CEO
CEO / President 10 613
Value: $296.0K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT VERA THERAPEUTICS, INC.
Vera Therapeutics
Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with immunoglobulin A nephropathy. It is also developing MAU868, a monoclonal antibody for the treatment of ...
GOLDEN STAR
Ticker Change Signal Date
GPOR
$158.45
6.03% Aug 06
FCX
$62.63
12.61% Jul 31
BIIB
$202.19
2.44% Jul 24
TSCO
$30.32
14.18% Jul 23
S
SW
$43.71
8.88% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE